S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:SBPH

Spring Bank Pharmaceuticals (SBPH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$1.21
$10.39
52-Week Range
N/A
Volume
N/A
Average Volume
177,606 shs
Market Capitalization
$122.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SBPH stock logo

About Spring Bank Pharmaceuticals Stock (NASDAQ:SBPH)

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of a range of cancers and inflammatory diseases using its proprietary small molecule nucleotide platform. The company is developing SB 11285, a next-generation immunotherapeutic cyclic dinucleotide for the treatment of selected cancers; novel STING antagonist compounds for the treatment of autoimmune and inflammatory diseases; and novel platform to enable the targeted delivery of payload molecules. It has a collaboration agreement with with Roche to explore the co-administration of SB 11285. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Hopkinton, Massachusetts.

SBPH Stock News Headlines

When will interest rates go down?
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Man stabbed during street fight in Spring Bank West
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Spring Returns
St. Scholastica to open spring practice
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals(SBPH)
See More Headlines
Receive SBPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spring Bank Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2020
Today
4/19/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SBPH
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Net Income
$-24,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.16 per share

Miscellaneous

Free Float
N/A
Market Cap
$122.94 million
Optionable
Not Optionable
Beta
1.07
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Martin J. Driscoll (Age 61)
    Pres, CEO & Director
    Comp: $568.08k
  • Dr. Radhakrishna P. Iyer Ph.D. (Age 70)
    FRSC, Co-Founder & Chief Scientific Officer
    Comp: $452.04k
  • Ms. Lori C. Firmani (Age 47)
    VP of Fin., Treasurer, Principal Financial Officer & Principal Accounting Officer
  • Mr. Donald Mitchell MBA
    VP of Operations & Corp. Devel.
  • Mr. Garrett Winslow (Age 41)
    VP of Legal, Sec. & Gen. Counsel
  • Dr. Nezam H. Afdhal (Age 63)
    Chief Medical Officer
  • Dr. Atif Abbas
    VP and Head of Oncology & Immunology Clinical Devel.

SBPH Stock Analysis - Frequently Asked Questions

How were Spring Bank Pharmaceuticals' earnings last quarter?

Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) issued its quarterly earnings data on Sunday, November, 8th. The company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.06.

What other stocks do shareholders of Spring Bank Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spring Bank Pharmaceuticals investors own include Intelsat (I), AMC Entertainment (AMC), Bank of America (BAC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), SCYNEXIS (SCYX), Avadel Pharmaceuticals (AVDL) and China Unicom (Hong Kong) (CHU).

When did Spring Bank Pharmaceuticals IPO?

Spring Bank Pharmaceuticals (SBPH) raised $14 million in an initial public offering (IPO) on Friday, May 6th 2016. The company issued 1,100,000 shares at a price of $12.00-$14.00 per share. Dawson James Securities acted as the underwriter for the IPO.

This page (NASDAQ:SBPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners